XML Print


1- MOL Diagnostics Melbourne, Australian Institute of Medical and Clinical Scientists (AIMS) Melbourne, Victoria, Australia , mohammad_esfahan@yahoo.com
2- MOL Diagnostics Melbourne, Australian Institute of Medical and Clinical Scientists (AIMS) Melbourne, Victoria, Australia
3- Padtan Danesh Company, Tehran, Iran
4- Laboratory Medicine, Vahid Medical Laboratory, Isfahan, Iran
Abstract:   (2769 Views)
Background: Anti-centromere antibodies (ACA) are commonly detected by indirect immunofluorescence (IIF) on HEp-2 cells, typically producing the classic centromere pattern (AC-3). However, discrepancies between IIF and solid-phase immunoassays, such as ELISA, may complicate interpretation.
Case Presentation: We report the case of a 75-year-old woman who presented with progressive inflammatory polyarthritis, morning stiffness, dry mouth, photosensitivity, and mild exertional dyspnea. Antinuclear antibody (ANA) testing by IIF on HEp-2 cells demonstrated a multiple nuclear dots pattern (AC-6), with features resembling a CENP-F–like pattern (AC-14), rather than the typical centromere pattern. By contrast, solid-phase assays, including ELISA and immuno-dot blot, demonstrated anti-centromere antibody reactivity. Additional serologic findings included strong positivity for SSA/Ro60, Ro52/TRIM21, SSB/La, and DFS70 antibodies.
Conclusion: This case demonstrates that anti-centromere reactivity detected by solid-phase assays may occur despite the absence of a classic AC-3 pattern on IIF. The interpretation of discordant serologic findings requires careful integration of clinical features with complementary laboratory methods.
Full-Text [PDF 384 kb]   (531 Downloads)    
Research Article: Case Report | Subject: Immunology
Received: 2026/01/2 | Accepted: 2026/06/6

References
1. Russo K, Hoch S, Dima C, Varga J, Teodorescu M. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol. 2000;27(1):142-8. [View at Publisher] [PMID] [Google Scholar]
2. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005;32(8):1488-94. [View at Publisher] [PMID] [Google Scholar]
3. Mahler M, You D, Baron M, Taillefer SS, Hudson M, Fritzler MJ, et al. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta. 2011;412(21-22):1937-43. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA Patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879-89. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Andrade LEC, Klotz W, Herold M, Musset L, Damoiseaux J, Infantino M, et al. Reflecting on a decade of the International Consensus on ANA Patterns (ICAP):Accomplishments and challenges from the perspective ofthe 7th ICAP workshop. Autoimmun Rev. Autoimmun Rev. 2024 ;23(9):103608. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Von Muhlen CA, Garcia-De La Torre I, Infantino M, Damoiseaux J, Andrade LEC, Carballo OG, et al. How to report the antinuclear antibodies (anti-cell antibodies) teston HEp-2 cells: guidelines from the ICAP initiative. Immunol Res. 2021;69(6):594-608. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. International Consensus on ANA Patterns (ICAP). AC-14 CENP-F-like pattern. Available from:https://www.anapatterns.org/view_pattern.php?pattern=14 Accessed 2026. [View at Publisher]
8. Hur K, Jearn LH, Kim TY. Centromere protein-F-like pattern in a patient with rheumatoid arthritis. Ann Lab Med. 2019;39(2):227-8. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.